Intersection of Computing and Biotech Panel Discussion
#WESTorg

Listen to the inspiring journeys of successful women and men leaders in science as they talk about their pathways to success. Highlights will include details on their career paths, obstacles they overcame, things that helped them along the way, and tips and strategies that can also work for you. This is a great opportunity for you to meet and network with the movers and shakers in the local science ecosystem.

PANELISTS
Sandra Glucksmann, Entrepreneur in Residence at Third Rock Ventures
Jonathan Sheffi, Product Manager for Genomics & Life Sciences at Google Cloud

Additional panelists will be added soon

  

Alexandra (Sandra) Glucksmann is an Entrepreneur-in-Residence at Third Rock Ventures in Boston, Massachusetts where she is focused on new company formation. She has nearly 25 years of R&D leadership and operations experience. Most recently, Alexandra served as chief operating officer of Editas Medicine Inc., which she joined as a founder and first employee. Editas is a gene editing company whose mission is to translate its genome editing technology into a novel class of human therapeutics. Previously, she was senior vice president of R&D at Cerulean Pharma, which she also joined at its founding. Prior to joining Cerulean in 2006, she spent 13 years at Millennium Pharmaceuticals, which she joined in 1993 as one of its first scientists. At Millennium, she held a series of science positions with increasing responsibility, ultimately becoming vice president of all platform technology groups before moving into a senior role in strategic program management and operations. She was a post-doctoral fellow at the Massachusetts Institute of Technology and holds a Ph.D. with honors from the University of Chicago.

Jonathan Sheffi is the Product Manager for Genomics & Life Sciences at Google Cloud. Previously, he was cofounder and CEO at Curoverse, a company that built an open source platform for managing and processing biomedical data (acquired by Veritas Genetics in 2017). He has spent many years in the biotechnology industry, including roles with Novartis Diagnostics, Amgen, Accenture, and the Broad Institute. He holds an MBA from Harvard, an MEng in computational molecular biology from MIT, and bachelor's degrees in mathematics and in computer science, also from MIT.

 

Date and Time:  
February 22, 2018
6:00 - 8:30 PM

Agenda:  

5:50-6:10pm: Registration, mingling, and pizza
6:10-6:30pm: Facilitated networking
6:30-7:45pm: Panel Discussion
7:45-8:30pm: Optional networking

 

Location:  
Broad Institute of MIT and Harvard, 415 Main Street, Monadnock Room, Cambridge, MA 02142

Map and Parking Info

We appreciate the Broad Institute donating the use of their event space.  

 

 

Cost:   
$0

Sponsored by Silicon Therapeutics 

 

Registration is currently closed as the sponsor is considering moving the date.